SIEMENS HEALTHINEERS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.8 EUR | -0.74% |
|
-4.87% | -3.42% |
| Mar. 27 | SIEMENS HEALTHINEERS : JP Morgan reiterates its Buy rating | ZD |
| Mar. 27 | SIEMENS HEALTHINEERS : Deutsche Bank reaffirms its Buy rating | ZD |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company is in debt and has limited leeway for investment
- The company benefits from high valuations in earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -3.42% | 60.89B | A- | ||
| +2.64% | 207B | B | ||
| +1.80% | 175B | B- | ||
| +8.59% | 132B | B- | ||
| +16.47% | 99.1B | A- | ||
| +12.71% | 52.04B | B+ | ||
| -6.61% | 45.48B | B+ | ||
| -4.53% | 38.81B | A | ||
| +9.27% | 38.77B | - | ||
| +3.97% | 26.09B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SHL Stock
- Ratings Siemens Healthineers AG
